Pediatric rheumatology

Glucocorticoid tapering early in the course of juvenile SLE: association with lupus low disease activity state and outcomes

Lupus Sci MedPublished Retrospective cohort study

Authors' conclusion

Successful GC tapering is feasible and does not increase the risk of flares during the early disease phase. However, flares are common and adversely affect GC tapering.

Study context

Population
Children with moderate-to-severe juvenile SLE, 2012–2022
Participants
80 children
Exposure
Successful glucocorticoid (GC) tapering within the first year vs no successful tapering
  • Successful taperingn = 50
Outcome
Successful GC tapering and risk of flares
Follow-up
First year of treatment
Methodological detailslinear mixed-effects model, Cox regression, logistic regression
  • Linear mixed-effects model
  • Cox regression
  • Logistic regression

Main finding

As reported in the abstract

Successful GC tapering within the first year

Successful tapering

62.5%

50

Flares observed
23 (28.8%)
GC tapering trajectories similar based on flare observations
P > 0.05

Observational data: associations, not effects.

Further findings

OutcomeORP value
Positive anti-dsDNA at twelfth month and odds of flares4.8P = 0.008

Initial GC dose in patients without flares

Patients without flares received significantly higher initial GC doses
P = 0.046

Childhood lupus low disease activity state (cLLDAS) achievement · twelfth month

cLLDAS achieved
40 (50%)
cLLDAS achievement not protective against future flares

Original publication

Glucocorticoid tapering early in the course of juvenile SLE: association with lupus low disease activity state and outcomes. Lupus Sci Med. Published 27 May 2025. doi:10.1136/lupus-2024-001415

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.